Amarin Corp Plc\uk
AMRNNasdaqCIK 897448HealthcareFiscal year ends Dec 31
Reports and events: 423 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2807:05 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-435082 |
| 2026-10-2807:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-435081 |
| 2026-08-2718:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-26-000972 |
| 2026-07-2916:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-323845 |
| 2026-07-2916:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323841 |
| 2026-05-1521:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-224771 |
| 2026-04-2907:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-188940 |
| 2026-04-2907:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-188935 |
| 2026-04-1017:00 ET | DEF 14A | Proxy statementPeriod 2026-04-10 | 0001193125-26-151417 |
| 2026-03-2717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-129334 |
| 2026-03-0217:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-085818 |
| 2026-02-2507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-068511 |
| 2026-01-0807:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-006992 |
| 2025-10-2907:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-254621 |
| 2025-10-2907:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-254620 |
| 2025-10-2217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-246973 |
| 2025-07-3007:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-099879 |
| 2025-07-3007:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099878 |
| 2025-07-0320:00 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000950170-25-093444 |
| 2025-06-2407:05 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-089218 |
| 2025-05-1517:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-072817 |
| 2025-05-0707:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064981 |
| 2025-05-0707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064980 |
| 2025-04-2916:20 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-060165 |
| 2025-04-1007:30 ET | DEF 14A | Proxy statementPeriod 2025-05-13 | 0000950170-25-052674 |
| 2025-04-0907:35 ET | 8-K | 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-052307 |
| 2025-04-0707:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-051353 |
| 2025-03-2816:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-046873 |
| 2025-03-2520:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-25-000466 |
| 2025-03-1207:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-037620 |
| 2025-03-1207:05 ET | 8-K | 2.02 Results of operations; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-037618 |
| 2024-12-1816:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-137894 |
| 2024-11-2216:49 ET | 8-K | 3.01 Delisting notice | 0000950170-24-130263 |
| 2024-10-3016:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-118990 |
| 2024-10-3016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-118988 |
| 2024-10-0716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-113227 |
| 2024-07-3107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-088234 |
| 2024-07-3107:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-088233 |
| 2024-07-2917:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-087391 |
| 2024-06-0407:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-068298 |
| 2024-05-2920:29 ET | 8-K | 3.01 Delisting notice | 0000950170-24-065585 |
| 2024-05-0107:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-050889 |
| 2024-05-0107:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-050886 |
| 2024-04-2212:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-046290 |
| 2024-04-0308:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-040675 |
| 2024-03-0408:00 ET | DEF 14A | Proxy statementPeriod 2024-04-18 | 0000950170-24-024353 |
| 2024-02-2907:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-022636 |
| 2024-02-2907:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-022635 |
| 2024-01-2607:00 ET | 8-K | 3.01 Delisting notice | 0000950170-24-007688 |
| 2024-01-1007:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-003511 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:23 ET. Listed shows no prices and gives no investment advice.